The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Heterogeneity in Primary Structure, Post-Translational Modifications, and Germline Gene Usage of Nine Full-Length Amyloidogenic κ1 Immunoglobulin Light Chains
Open accessAbstract
Immunoglobulin light chain amyloidosis is a protein misfolding disease in which a monoclonal immunoglobulin (Ig) light chain (LC) with a critically folded beta-conformation self-aggregates to form highly ordered, nonbranching amyloid fibrils. The insoluble nature of amyloid fibrils ultimately results in the extracellular deposition of the LC in tissues and organs throughout the body. Structural features that confer amyloidogenic properties on an Ig LC likely include amino acid sequence variations and post-translational modifications, but the specific natures of these changes remain to be defined. As part of an exploration of the effective range of amyloidogenic modifications, this study details the structural and genetic analyses of nine kappa1 LC proteins. Urinary LCs were purified by size exclusion chromatography using FPLC, and structural analyses were performed by electrospray ionization, matrix-assisted laser desorption/ionization, and tandem mass spectrometry. RT-PCR amplification, cloning, and sequencing of the monoclonal LC genes were accomplished using bone marrow-derived mRNA. Clinical data were reviewed retrospectively. Characterization of the urinary kappa1 LCs revealed extensive post-translational modification in all proteins, in addition to somatic mutations expected on the basis of results from genetic analyses. Post-translational modifications included disulfide-linked dimerization, S-cysteinylation, glycosylation, fragmentation, S-sulfonation, and 3-chlorotyr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In other disease areas, including organ fibrosis, several examples exist in which a mutation at one site can affect PTM profiles elsewhere on the protein 53-55 .”
From How many human proteoforms are there? (2018) · cites this paper as [53]
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385 · cited 1×
“Proteins were initially separated by SDS—PAGE, electrophoretically transferred to nitrocellulose, and then visualized by antibody-linked staining (28,29).”
MethodWeber, K., & Osborn, M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94333-4 · Cited by 20,298 · cited 1×
“Electrophoresis on 10-15% gradient polyacrylamide gels (26,27) was performed using an automated Phast system (GE Healthcare Bio-Sciences).”
MethodMolecular Mechanisms of Amyloidosis
Merlini, G., & Bellotti, V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023144 · Cited by 1,920 · cited 4×
“(4) Fragmentation—Evidence of extensive fragmentation was found in one LC protein sample.”
BackgroundInfluentialTowbin, H., Staehelin, T., & Gordon, J. (1992) · PubMed · Cited by 800
Skinner, M., Sanchorawala, V., Seldin, D. C., Dember, L. M., Falk, R. H., Berk, J. L., Anderson, J. J., O'Hara, C., Finn, K. T., Libbey, C. A., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-2-200401200-00008 · Cited by 618 · cited 2×
“Although disease presentation usually involves a relatively minor bone marrow abnormality, AL is devastating in the usually massive extent of organ system amyloid deposits and in the short survival that accompanies the disease (2).”
BackgroundSelf-citationElimination of Oxidative Degradation during the per-O-Methylation of Carbohydrates
Ciucanu, I., & Costello, C. E. (2003) · Journal of the American Chemical Society · doi:10.1021/ja035660t · Cited by 287 · cited 2×
“The PNGase F-released glycans were permethylated using a standard protocol (31, 33).”
MethodSelf-citationA Three-Stage Kinetic Model of Amyloid Fibrillation
Lee, C.-C., Nayak, A., Sethuraman, A., Belfort, G., & McRae, G. J. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.098608 · Cited by 278 · cited 1×
“The prevailing paradigm for amyloidogenesis holds that the precursor amyloid protein becomes structurally destabilized, transitions through a series of intermediate conformations, and ultimately adopts a non-native assembly that favors selfaggregation (12-17).”
Wogulis, M., Wright, S., Cunningham, D., Chilcote, T., Powell, K., & Rydel, R. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2381-04.2005 · Cited by 233 · cited 1×
“The prevailing paradigm for amyloidogenesis holds that the precursor amyloid protein becomes structurally destabilized, transitions through a series of intermediate conformations, and ultimately adopts a non-native assembly that favors selfaggregation (12-17).”
BackgroundBellotti, V., Mangione, P., & Merlini, G. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4248 · Cited by 190
Bizzozero, O. A., DeJesus, G., Callahan, K., & Pastuszyn, A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20587 · Cited by 134 · cited 1×
“S-cysteinylation of other proteins has been linked to elevated levels of homocysteine, a biomolecule which is converted to cysteine in oxidizing environments (40-42).”
Background
Research works printed but not linked: 40
- Falk R. H., 1997, N. Engl. J. Med., 337
- Falk R. H., 2000, 45, 107−137.
- Lansbury P. T., Jr., 1999, Proc. Natl. Acad. Sci. U.S.A. 96
- Stevens F. J., 1995, Biochemistry 34, 10697−10702.
- Liepnieks J. J., 1990, Mol. Immunol. 27, 481−485.
- Myran T., 2004, Amyloid 11, 109−112.
- Solomon A., 1998, Proc. Natl. Acad. Sci. U.S.A. 95
- Hurshman A. R., 2004, Biochemistry 43, 7365−7381.
- Kelly J. W., 2000, Nat. Struct. Biol. 7, 824−826.
- Konno T., 2001, Protein Sci. 10
- Lee C. C., 2007, Biophys. J., 92
- Thirumalai D., 2003, Curr. Opin. Struct. Biol. 13, 146−159.
- Liao R., 2001, Circulation 104, 1594−1597.
- Brenner D. A., 2004, Circ. Res. 94, 1008−1010.
- Omtvedt L. A., 2000, Amyloid 7, 227−244.
- Stevens F. J., 2000, Amyloid 7, 200−211.
- Prokaeva T., 2007, Arthritis Rheum. (in press).
- Lim A., 2001, Anal. Biochem., 295, 56
- Laemmli U. K., 1970, Nature 227, 680−685.
- Jagersten C., 1988, Electrophoresis 9, 662−665.
- Conboy J. J., 1992, Biol. Mass Spectrom. 21, 397−407.
- Giudicelli V., 2004, Nucleic Acids Res. 32, W435−440.
- Reinhold V. N., 1995, Anal. Chem. 67, 1772−1784.
- Rogozin I. B., 1992, Biochim. Biophys. Acta, 1171, 18
- Abraham R. S., 2002, Clin. Chem. 48
- Grey H. M., 1968, Clin. Exp. Immunol. 3, 277−285.
- Peterson P. A., 1971, Eur. J. Clin. Invest., 1
- Schormann N., 1995, Proc. Natl. Acad. Sci. U.S.A. 92
- Bar-Or D., 2005, Prenatal Diagn. 25, 245−249.
- Chen W., 1999, J. Exp. Med., 189
- Watarai H., 2000, Proc. Natl. Acad. Sci. U.S.A. 97
- Foss G. S., 1998, Scand. J. Immunol., 47
- Milstein C. P., 1971, Biochem. J., 121
- Toft K. G., 1985, Biol. Chem. Hoppe-Seyler 366, 617−625.
- Dimroth P., 1982, Biosci. Rep. 2, 849−860.
- Okamura T., 1998, J. Nutr. Sci. Vitaminol., 44
- Abraham R. S., 2003, Blood 101, 3801−3808.
- Gallo G., 1996, Am. J. Pathol., 148
- Schiffer M., 1996, Am. J. Pathol., 148
- Abbreviations, immunoglobulin
Cited by
How many human proteoforms are there?
Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2576 · Cited by 907
Self-citationAmyloidogenic and Associated Proteins in Systemic Amyloidosis Proteome of Adipose Tissue
Lavatelli, F., Perlman, D. H., Spencer, B., Prokaeva, T. B., McComb, M. E., Théberge, R., Connors, L. H., Bellotti, V., Seldin, D. C., Merlini, G., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700545-mcp200 · Cited by 153
Self-citationGuan, J., Mishra, S., Qiu, Y., Shi, J., Trudeau, K. M., Las, G., Liesa, M., Shirihai, O. S., Connors, L. H., Seldin, D. C., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404190 · Cited by 141
“Antibodies were obtained from Santa Cruz Biotechnology (TFEB), Cell signaling Technology (total and phosphorylated S6 Kinase, COX4), MBL (LC3), R&D Systems (GAPDH), Sigma (b-actin), Abcam (active caspase 3) and Abnovo (p62).”
MethodInfluentialSelf-citationThe utility of MASS‐FIX to detect and monitor monoclonal proteins in the clinic
Milani, P., Murray, D. L., Barnidge, D. R., Kohlhagen, M., Mills, J. R., Merlini, G., Dasari, S., & Dispenzieri, A. A. (2017) · American Journal of Hematology · doi:10.1002/ajh.24772 · Cited by 135
Treatment of Immunoglobulin Light Chain Amyloidosis
Dispenzieri, A. A., Buadi, F. K., Kumar, S. K., Reeder, C. B., Sher, T., Lacy, M. Q., Kyle, R. A., Mikhael, J. R., Roy, V., Leung, N., et al. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.06.009 · Cited by 128
Metadata
- Authors
- Connors, L. H., Jiang, Y., Budnik, M., Théberge, R., Prokaeva, T., Bodi, K. L., Seldin, D. C., Costello, C. E., & Skinner, M.
- Affiliations
- Boston University (US)
- Corresponding author
- Connors, Lawreen H.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2007-11-16
- Volume
- 46
- Issue
- 49
- Pages
- 14259-14271
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- PMC
- PMC2912213
- OpenAlex
- W1986202137
- Cited by
- 62
- References
- 22
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 6
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1s10rr010493-01)
- National Heart, Lung, and Blood Institute (P01HL068705, P01HL68705)
- National Center for Research Resources (S10 RR15942, P41-RR-10888, S10 RR-10493, S10RR015942, P41RR010888)
- Topics
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- AL amyloidosis, amyloidogenicity, post-translational modification, germline gene usage, somatic mutations, glycosylation, 3-chlorotyrosine, monoclonal immunoglobulin light chains, protein misfolding, light chain variable region
- MeSH terms
- Adult, Aged, Amino Acid Sequence, Amyloidosis, Chromatography, Gel, Electrophoresis, Polyacrylamide Gel, Female, Humans, Immunoglobulin kappa-Chains, Male, Middle Aged, Protein Processing, Post-Translational, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Spectrometry, Mass, Electrospray Ionization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heterogeneity in Primary Structure, Post-Translational Modifications, and Germline Gene Usage of Nine Full-Length Amyloidogenic κ1 Immunoglobulin Light Chains. https://app.cochat.ai/papers/10.1021/bi7013773
- The paper
- Connors, L. H., Jiang, Y., Budnik, M., Théberge, R., Prokaeva, T., Bodi, K. L., Seldin, D. C., Costello, C. E., & Skinner, M. (2007). Heterogeneity in Primary Structure, Post-Translational Modifications, and Germline Gene Usage of Nine Full-Length Amyloidogenic κ1 Immunoglobulin Light Chains. Biochemistry. https://doi.org/10.1021/bi7013773
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.